Regional anesthesia

Comparison between low-volume local anesthetic with intravenous dexamethasone and conventional volume without dexamethasone for superior trunk block after arthroscopic shoulder surgery: a randomized controlled non-inferiority trial

Reg Anesth Pain MedPublished Randomised controlled trial

Authors' conclusion

Superior trunk block using low-volume local anesthetic with intravenous dexamethasone can reduce the incidence of diaphragmatic paresis while providing non-inferior analgesic duration compared with the conventional volume of local anesthetic in patients undergoing arthroscopic shoulder surgery.

Study context

Population
Adults undergoing arthroscopic shoulder surgery under GA
Participants
84 adults
Comparison
Treatment vs Control
Primary endpoint
Co-primary: (1) duration of analgesia (block completion to surgical pain NRS ≥4; non-inferiority margin 3 hours); (2) incidence of diaphragmatic paresis (M-mode ultrasonography in PACU)
Methodological detailsnon-inferiority
  • Non-inferiority

Primary result

As reported in the abstract

Duration of analgesia; diaphragmatic paresis

Treatment

12.4

mean · SD 6.8 · hours

Control

11.2

mean · SD 4.6 · hours

Treatment

45.2%

Control

85.4%

Treatment vs ControlMean difference, hours (95% CI)P value
Duration of analgesia; non-inferiority criteria met (margin 3 hours)
−1.2(−3.8 to 1.3)
P < 0.001for non-inferiority
Treatment vs ControlRelative risk (97.5% CI)P value
Diaphragmatic paresis
0.53(0.35–0.80)
P < 0.001

Non-inferiority margin 3 as printed, not drawn

Original publication

Comparison between low-volume local anesthetic with intravenous dexamethasone and conventional volume without dexamethasone for superior trunk block after arthroscopic shoulder surgery: a randomized controlled non-inferiority trial. Reg Anesth Pain Med. Published 29 September 2023. doi:10.1136/rapm-2023-104520

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.